Answers are grounded in this paper and cite their sources.
High Resolution Image Download MS PowerPoint Slide Stimulator of interferon genes (STING) is a transmembrane endoplasmic reticulum (ER) resident protein involved in innate immunity. STING activation occurs by binding of cyclic guanosine-(2′→5′)-monophosphate-adenosine-(3′→5′)-monophosphate (2′,3′-cGAMP) to STING, which leads to downstream production of type 1 interferons (IFN-1). We generated molecular dynamics (MD) equilibrated agonist and antagonist models of human STING (hSTING) for computer-based screening and now report the discovery of clonixeril (CXL) as the most potent non-nucleotide hSTING modulator discovered to date. We demonstrate in vitro and in cellulo that CXL has two modes of interaction with hSTING, one with an EC 50 above 1 nM and the other with an EC 50 in the 1 fM–100 aM range (10 –15 –10 –16 M). In cell-based experiments, when CXL is titrated below 1 nM, it displays inverse dose-dependent antagonistic behavior toward hSTING. We have substantiated that CXL displays this exceptionally strong inhibitory effect on hSTING mediated IFN-1 production using a THP-1 cell luciferase reporter for interferon regulatory factor 3 (IRF3). Further characterization of CXL was performed in HEK293 cells by using biophysical and biochemical techniques.
No takes yet. Share an insight, caveat, or question.
Sparks et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: